Description
Method: | DNA Sequencing |
Comment: | Samples received on holidays will be reported in next schedule / next working day. |
Price: | 12000.00 |
Report: | Sample Mon / Wed / Fri by 9 am; Report 6 Working days |
Usage: | Maternal Blood for Fetal DNA (MBFD) is a non-invasive prenatal test (NIPT) that analyzes a mother’s blood to assess the risk of fetal chromosomal disorders. It can also detect microdeletion syndromes. What it tests for Trisomies: MBFD can detect trisomies 21 (Down syndrome), 18 (Edwards syndrome), and 13 (Patau syndrome). Microdeletion syndromes: MBFD can detect microdeletion syndromes like DiGeorge, William, Prader Willi, and Angelman. Sex: MBFD can provide information about the sex of the fetus. |
Doctor Specialty: | Gynecologist |
Disease: | Prenatal Diagnosis |
Components: | *Trisomy detection for 13, 18 & 21 Chromosomes |
Courier Charges: | 0.00 |
Home Collection: | Available |
Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information: | Test is valid between 10-24 weeks of gestation. Duly filled Form G AND MBFD/NIPT consent form (Form 21) is mandatory. Samples shall be accepted only from registered genetics clinics under PCPNDT Act. |
Non-Invasive Prenatal Testing (NIPT)
NIPT, also known as non-invasive prenatal screening (NIPS), is a blood test during pregnancy that screens for the risk of certain chromosomal abnormalities in the fetus by analyzing fetal DNA fragments in the mother’s blood.
What it screens for
NIPT primarily screens for the risk of Down syndrome (trisomy 21), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and sex chromosome abnormalities. Some tests also screen for other chromosomal disorders.
When is it performed
NIPT can be done as early as 10 weeks and is most effective between 10 and 22 weeks of pregnancy.
How it works
The test analyzes cell-free DNA (cfDNA) from the placenta in the mother’s bloodstream.
Accuracy and interpretation of results
NIPT is highly accurate, especially for Down syndrome, but it is a screening test, not a diagnostic one. Results indicate “low risk” or “high risk,” with high-risk results requiring further diagnostic testing.
Who should consider NIPT
NIPT is an option for all expectant mothers, particularly those with a higher risk of genetic disorders due to factors like maternal age (35 or older), family history, or abnormal results on other prenatal tests.
NIPT vs. traditional prenatal tests
NIPT has advantages over traditional methods, including higher accuracy, earlier results, and no risk to the baby as it’s a blood test.
Cost
In India, NIPT costs generally range from ₹9000 to ₹12000, depending on the specifics of the test.
For medical advice or a diagnosis, consult a professional.